હોમ › સ્થૂળતા › ટેક્સાસ › Houston
Houston, TX માં સ્થૂળતા ક્લિનિકલ ટ્રાયલ્સ
Houston (લગભગ 30 માઇલની અંદર) ની સાઇટ્સ પર સ્થૂળતા માટે 43 અભ્યાસો ભાગીદારો શોધી રહ્યા છે. કોઈ અભ્યાસ ખોલો અને જુઓ કે કોઈ જોડાઈ શકે છે અને અભ્યાસ ટીમ સાથે સંપર્ક કેવી રીતે કરવો.
અધિકૃત અભ્યાસ ટેક્સ્ટ (અંગ્રેજી)
અહીં અભ્યાસ માટે ભરતી કરી રહ્યા છો? આ પેજની ટોચ પર તેને ફીચર કરો — 30 દિવસ માટે $99 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ભરતી ચાલુ છેફેઝ 2
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 માઇલ દૂર
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ભરતી ચાલુ છેફેઝ 2
- Cardiovascular Specialists of Willowbrook, Houston
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
ભરતી ચાલુ છેફેઝ 3
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
ભરતી ચાલુ છેફેઝ 3
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ભરતી ચાલુ છેફેઝ 3
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ભરતી ચાલુ છેફેઝ 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
ભરતી ચાલુ છેફેઝ 3
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
ભરતી ચાલુ છેફેઝ 3
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- અને 1 વધુ
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 3
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ભરતી ચાલુ છેફેઝ 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
ભરતી ચાલુ છેફેઝ 3
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ભરતી ચાલુ છેફેઝ 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- અને 2 વધુ
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 3
- The University of Texas Health Science Center at Houston, Bellaire · 7 માઇલ દૂર
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ભરતી ચાલુ છેફેઝ 3
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · 7 માઇલ દૂર
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ભરતી ચાલુ છેફેઝ 2
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
ભરતી ચાલુ છેફેઝ 2સ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 3
- AURORA-2 Clinical Site, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ભરતી ચાલુ છેફેઝ 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- અને 3 વધુ
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
ભરતી ચાલુ છેફેઝ 2
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 3
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · 7 માઇલ દૂર
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ભરતી ચાલુ છેફેઝ 3
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ભરતી ચાલુ છેફેઝ 3સ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ભરતી ચાલુ છેફેઝ 3
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ભરતી ચાલુ છેફેઝ 2
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
ભરતી ચાલુ છેફેઝ 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
ભરતી ચાલુ છેફેઝ 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7 માઇલ દૂર
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ભરતી ચાલુ છેફેઝ 3
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 માઇલ દૂર
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
ભરતી ચાલુ છેફેઝ 3
- Kailera Clinical Site, Bellaire · 7 માઇલ દૂર
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ભરતી ચાલુ છેફેઝ 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 માઇલ દૂર
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ભરતી ચાલુ છેફેઝ 3
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
ભરતી ચાલુ છેફેઝ 3
- Research Site, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ભરતી ચાલુ છેફેઝ 2
- Baylor Texas Children's Hospital, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ભરતી ચાલુ છેફેઝ 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- અને 1 વધુ
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ભરતી ચાલુ છેફેઝ 3
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Children's Nutrition Research Center, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છેભાગ લેનારાઓ માટે ચુકવણીનો ઉલ્લેખ કરે છે
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Lilli Health, Houston
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
ભરતી ચાલુ છે
- M D Anderson Cancer Center, Houston
Incretin Microdosing for Cardiometabolic Health in People With HIV
ભરતી ચાલુ છેફેઝ 2
- The University of Texas Health Science Center at Houston, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
ભરતી ચાલુ છેફેઝ 2
- Baylor College of Medicine, Houston
RESET System Pivotal Trial (Rev F)
ભરતી ચાલુ છે
- Baylor College of Medicine, Houston
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
ભરતી ચાલુ છે
- Houston Methodist Hospital, Houston
અન્ય શહેરોમાં સ્થૂળતા ટ્રાયલ્સ
- Chicago, IL41 અભ્યાસો
- New York City, NY40 અભ્યાસો
- San Antonio, TX40 અભ્યાસો
- Washington, DC33 અભ્યાસો
- Orlando, FL31 અભ્યાસો
- Dallas, TX30 અભ્યાસો
- Boston, MA28 અભ્યાસો
- Las Vegas, NV27 અભ્યાસો
- Miami, FL27 અભ્યાસો
- Baltimore, MD25 અભ્યાસો
- Jacksonville, FL25 અભ્યાસો
- St. Louis, MO25 અભ્યાસો
Houston માં અન્ય અભ્યાસો
- નોન-સ્મોલ સેલ લંગ કેન્સર145 અભ્યાસો
- સ્તન કેન્સર126 અભ્યાસો
- કેન્સર (બધા પ્રકાર)121 અભ્યાસો
- મેટાસ્ટેટિક કેન્સર104 અભ્યાસો
- કોલોરેક્ટલ કેન્સર102 અભ્યાસો
- ઓવેરિયન કેન્સર89 અભ્યાસો
- એક્યુટ માયલોઇડ લ્યુકેમિયા85 અભ્યાસો
- ફેફસાનું કેન્સર78 અભ્યાસો
- પ્રોસ્ટેટ કેન્સર76 અભ્યાસો
- એન્ડોમેટ્રિયલ કેન્સર68 અભ્યાસો
- પેન્ક્રિએટિક કેન્સર61 અભ્યાસો
- મેલેનોમા59 અભ્યાસો
ClinicalTrials.gov પરથી, તારીખ 5 ઑક્ટો, 2026 ના ડેટા સાથે. દરેક અભ્યાસની પોતાની પાત્રતા શરતો હોય છે; અભ્યાસ ટીમ નક્કી કરે છે કે કોઈ જોડાઈ શકે છે કે નહીં.